📄 Cross-examination of Dr. John Gerdes (part 3) — Monday, August 7, 1995
Address:
C:\DEPT103\CRIMINAL\1995\AUG\7\CROSS-EXAMINATION-OF-DR-JOHN-G.DOC
TRIAL
▲ Day 130 of 167

Cross-examination of Dr. John Gerdes (part 3)

Witness: Dr. John Gerdes
Examiner: George Clarke
Called by: Defense • Date: Monday, August 7, 1995 • Utterances: 215
Clarke continued his cross-examination of defense DNA contamination expert Dr. John Gerdes, forcing concessions that Yamauchi used adequate controls (50% of all samples), that the DNA results from three labs are consistent with Simpson's guilt, and that Gerdes had no direct evidence of contamination in the Bronco samples. Clarke closed by pressing Gerdes on why the defense never sought retesting of remaining evidence, an implicit argument that Gerdes's contamination theory was speculative rather than falsifiable.
1 (The following proceedings were held in open court:)
2 THE COURT:

Proceed.

3 MR. CLARKE:

Thank you, your Honor.

4 MR. CLARKE:

Dr. Gerdes, with regard to the LAPD's DNA testing in this case, you have described previously that Mr. Yamauchi conducted PCR typing in this case on June 14th and June 15th, correct?

5 DR. GERDES:

Correct.

6 MR. CLARKE:

And in that testing he used the controls that you previously described as a result of my asking questions about reagent blanks and so forth, correct?

7 DR. GERDES:

Correct.

8 MR. CLARKE:

Now, your Honor, I have another document--one more document I would ask to be marked as People's I believe 572 which I have previously shown to counsel.

9 (Peo's 572 for id = slide)
10 MR. CLARKE:

And with the Court's permission I will display it on the elmo.

11 THE COURT:

Proceed.

12 MR. CLARKE:

Dr. Gerdes, can you see that?

13 DR. GERDES:

I would like to step down if I can.

14 MR. CLARKE:

That's fine.

15 (Witness complies.)
16 MR. CLARKE:

First of all, this particular document or slide, as it is now on the screen, have you had a chance to see that or take a look at it last week?

17 DR. GERDES:

I saw it briefly, yes.

18 MR. CLARKE:

And did you have an opportunity to calculate the total number of evidence samples, known standards and controls, that Mr. Yamauchi used in his testing in this case?

19 DR. GERDES:

Yes.

20 MR. CLARKE:

Now, with regard to--and there were two different dates for this testing; is that right?

21 DR. GERDES:

That's correct.

22 MR. CLARKE:

And on both June 14th and June 15th Mr. Yamauchi typed evidence samples?

23 DR. GERDES:

Yes.

24 MR. CLARKE:

He also typed known standards from the three people in this case?

25 DR. GERDES:

Yes.

26 MR. CLARKE:

And he also utilized a series of controls; is that right?

27 DR. GERDES:

Yes.

28 MR. CLARKE:

As far as the known standards, do you call those a control or not?

29 DR. GERDES:

They are in the sense that they are defined as coming from a single individual, and if you can find evidence of human DNA, additional human DNA, that is evidence of contamination.

30 MR. CLARKE:

So in a sense the known standards can act as a control, correct?

31 DR. GERDES:

Correct.

32 MR. CLARKE:

So that if a person was A, let's say a DQ-Alpha 1.1, 1.2, and you saw a 3 and a 4 showing up in addition to the 1.1 and 1.2, that is again another opportunity for contamination to signal itself at least in that sample?

33 DR. GERDES:

That's correct.

34 MR. CLARKE:

Now, as far as the total number of samples typed by Mr. Yamauchi, is it correct that including both June 14th and June 15th he typed a total of 42 different samples?

35 DR. GERDES:

That's correct.

36 MR. CLARKE:

That consisted of eighteen evidence samples, whether it is a stain from the sidewalk at Bundy or a sample from the Bronco, correct?

37 DR. GERDES:

Correct.

38 MR. CLARKE:

Or other samples that he typed as well?

39 DR. GERDES:

Correct.

40 MR. CLARKE:

He also typed the three known standards from the three individuals in this case; Mr. Simpson, Miss Brown and Mr. Goldman?

41 DR. GERDES:

That's correct.

42 MR. CLARKE:

The total number of evidence and known standards was 21; is that right?

43 DR. GERDES:

Yes.

44 MR. CLARKE:

And is it also correct that the total number of controls used in this case by Mr. Yamauchi on June 14th and 15th was 21?

45 DR. GERDES:

Yes.

46 MR. CLARKE:

Is it then correct that of the 42 samples typed by Mr. Yamauchi in this case on June 14th and June 15th, half of them, that is fifty percent, were controls?

47 DR. GERDES:

On this specific case, yes.

48 MR. CLARKE:

In your view is that an adequate number of controls for typing?

49 DR. GERDES:

It should be.

50 MR. CLARKE:

And in fact it is, isn't it?

51 DR. GERDES:

Yes.

52 MR. CLARKE:

All right. Thank you. Now, Dr. Gerdes, you have, last Wednesday and Thursday, repeatedly used terms like my interpretation, possibility and risk. Do you recall using those words?

53 DR. GERDES:

Yes.

54 MR. CLARKE:

And that was in reference to your testimony about the dangers of contamination in this case, correct?

55 DR. GERDES:

Yes.

56 MR. CLARKE:

You can't quantify that risk, can you?

57 DR. GERDES:

Umm--

58 MR. CLARKE:

That is, put a number on the risk?

59 DR. GERDES:

Well, if there were adequate blind proficiency studies at least you could have some idea about error rate, which would give you some idea of risk, and the other thing that you can do is, as I have done here, you can look at all of the testing around the time frame of the testing done on an instance case and see how many times errors were made and how many times there was evidence of contamination so they are--those are objective ways of measuring the amount of risk. But as to coming up with a number that is a specific number that is going to say eighty percent of the time you will make a mistake or something like that, no, you can't quantify it.

60 MR. CLARKE:

And in fact you testified about what you believe to be errors in the laboratory and we went through each of the five, correct?

61 DR. GERDES:

Yes, we did.

62 MR. CLARKE:

Now, as far as your laboratory's work in diagnosis of diseases, you produce results that ultimately to go a doctor, correct?

63 DR. GERDES:

Correct.

64 MR. CLARKE:

And a doctor is required to notify that patient of risks no matter how unlikely they are to occur, correct?

65 DR. GERDES:

Yes.

66 MR. CLARKE:

Are you aware of the non-bloodstain evidence in this case?

67 DR. GERDES:

You mean fibers, hair, et cetera?

68 MR. CLARKE:

All the other evidence in this case?

69 MR. SCHECK:

Objection.

70 DR. GERDES:

Peripherally?

71 MR. SCHECK:

Outside the scope, irrelevant.

72 THE COURT:

Overruled.

73 MR. CLARKE:

When you say "Peripherally," doctor, what do you mean?

74 DR. GERDES:

Well, I certainly did not review specific documents as to those things outside of my field, but I am aware of them because of media coverage and just like anybody else would be.

75 MR. CLARKE:

So watching TV, that would be one source?

76 DR. GERDES:

Yes.

77 MR. CLARKE:

Reading the newspaper?

78 DR. GERDES:

Yes.

79 MR. CLARKE:

Reading magazines, if you do?

80 DR. GERDES:

Yes.

81 MR. CLARKE:

You have also testified that it is ultimately for the jury to decide the reliability of the scientific evidence in this case. Do you recall saying that?

82 DR. GERDES:

Yes.

83 MR. CLARKE:

Is it also correct that it is ultimately for the jury to decide whether in fact any contamination occurred in this case?

84 DR. GERDES:

That is up to their discretion, yes.

85 MR. CLARKE:

All you have told this jury is that there might be contamination in this case, correct?

86 DR. GERDES:

I believe I have documented as precisely as I can the level of contamination that exists, and from that point on I have suggested how that may have or tried to explain how that would have an impact on the case. From that point on it is up to the jury to deal with that--that piece of evidence and in the context of the whole case.

87 MR. CLARKE:

And you have talked about, Dr. Gerdes, possibilities, not what actually happened, correct?

88 MR. SCHECK:

Objection, calls for conclusions.

89 THE COURT:

Sustained. It is argumentative.

90 MR. CLARKE:

You have spoken, you have described what you had believed to be possibilities in this case; is that right?

91 MR. SCHECK:

Argumentative.

92 THE COURT:

Overruled.

93 DR. GERDES:

I have, as objectively as possible, evaluated the level of contamination at LAPD, the errors that I felt were a result of that, the evidence of cross-contamination in the reference samples and the implications of that in terms of the evidence in this case. That is what I have attempted to explain.

94 MR. CLARKE:

You have spoken about what could happen; not what did happen, correct?

95 DR. GERDES:

I don't have a hundred percent assurance that this did happen. I have no scientific confidence that it couldn't have happened.

KEY QUOTE
96 MR. CLARKE:

Dr. Gerdes, the results in this case from three different laboratories are consistent with the Defendant's blood being left at the crime scene, aren't they?

97 DR. GERDES:

The results from the three labs as far as reported results, yes.

98 MR. CLARKE:

They are consistent with mixtures of DNA from the Defendant, Ronald Goldman and Nicole Brown being found in the Ford Bronco; isn't that correct?

99 DR. GERDES:

The results are consistent with that as they are detected.

100 MR. CLARKE:

Incidentally, you haven't suggested to this jury that the Defendant's reference sample cross-contaminated the evidence taken from the Bronco, have you?

101 DR. GERDES:

The fact that I have some indications of cross-contamination in those reference samples obviously increases again the risk that it could cross-contaminate something else.

102 MR. CLARKE:

Dr. Gerdes, what I'm asking you is you haven't suggested to this jury that the Defendant's reference sample cross-contaminated any evidence in the Bronco, have you?

103 DR. GERDES:

His particular sample?

104 MR. CLARKE:

Correct.

105 DR. GERDES:

It is hard to tell. I mean, I have no evidence--specific evidence, hard evidence of that.

106 MR. CLARKE:

You don't have any evidence of it whatsoever, do you?

107 DR. GERDES:

I have some--some evidence that the reference samples themselves may have cross-contaminated. At that point everything becomes suspicious.

108 MR. CLARKE:

Dr. Gerdes, what I'm asking you is you don't have any evidence whatsoever that the Defendant's reference sample cross-contaminated any of the stains from the Bronco?

109 DR. GERDES:

I don't have any direct evidence of that, no.

110 MR. CLARKE:

Where in the history of these samples did the Defendant's reference sample come into even potential contact with the Bronco evidence samples?

111 DR. GERDES:

There are other items that were collected at that residence who arguably may have come from the Defendant and it may not have been the reference sample, but it may have been some of those items.

112 MR. CLARKE:

Dr. Gerdes, what I'm asking you is with regard to the Defendant's reference sample, when did it come into any potential contact with the Bronco evidence stains?

113 DR. GERDES:

It didn't.

114 MR. CLARKE:

The results in this case, Dr. Gerdes, are consistent with the Defendant's blood leading up to and inside his home on Rockingham; isn't that correct?

115 DR. GERDES:

There is--the type results appear that way, yes.

116 MR. CLARKE:

Those results are consistent with Nicole Brown and Ronald Goldman's blood being found on the glove at Rockingham, correct?

117 DR. GERDES:

Again, there are multiple explanations. That is one explanation.

118 MR. CLARKE:

Dr. Gerdes, didn't you concede last week that the RFLP matches to the two victims on the glove were correct?

119 DR. GERDES:

Yes.

120 MR. CLARKE:

Dr. Gerdes, isn't it true that the DNA type results from the laboratories in this case are consistent with Nicole Brown's and Mr. Simpson's blood being on the sock found at the residence?

121 MR. SCHECK:

Your Honor, this is asked and answered five times.

122 THE COURT:

Overruled.

123 DR. GERDES:

Yes, that is true.

124 MR. CLARKE:

And in fact you have conceded that much during your testimony, correct?

125 DR. GERDES:

I have.

126 MR. CLARKE:

Now, five probes is significant, correct?

127 MR. SCHECK:

Objection, asked and answered.

128 THE COURT:

We have gone through this part.

129 MR. CLARKE:

When you conduct your paternity testing you look at individual probes, correct?

130 DR. GERDES:

Correct.

131 MR. CLARKE:

You look at more than one probe because a father might be excluded as being the father of a particular child, correct?

132 MR. SCHECK:

Objection, asked and answered.

133 THE COURT:

Overruled.

134 DR. GERDES:

Yes.

135 MR. CLARKE:

And in fact you look at routinely five different genetic markers; is that right?

136 DR. GERDES:

That's correct, for doing DNA only.

137 MR. CLARKE:

Just counting DNA, right?

138 DR. GERDES:

Yes.

139 MR. CLARKE:

And you are looking at each of those markers, this is a potential father or this person who might be the father excluded as the father of that child, correct?

140 DR. GERDES:

Correct.

141 MR. CLARKE:

Once you look at those probes, you then estimate how rare is that match at one probe?

142 MR. SCHECK:

Your Honor, objection.

143 THE COURT:

Sustained. We have gone through this already.

144 MR. CLARKE:

Dr. Gerdes, one of the concerns you have experienced in forensics is the fact that a sample may be small and you may not be able to retest it, correct?

145 DR. GERDES:

Correct.

146 MR. CLARKE:

Now, as far as errors--and you described how in medical diagnostics if a patient dies because of a misdiagnosis you know you have made a mistake; is that right?

147 DR. GERDES:

That is a pretty drastic example, but yes.

148 MR. CLARKE:

And you described the fact last week that in your view there is no independent way of assessing whether or not mistakes are made in the forensic setting? Do you recall that?

149 DR. GERDES:

I believe that is true.

150 MR. CLARKE:

Are you aware of remaining evidence in this case that can be retested?

151 DR. GERDES:

I'm not aware of any evidence that hasn't been handled by the LAPD that can be retested.

152 MR. CLARKE:

Objection, move to strike, nonresponsive.

153 THE COURT:

Overruled.

154 MR. CLARKE:

Dr. Gerdes, are you aware of remaining evidence in this case that can be retested?

155 DR. GERDES:

There are items that can be retested.

156 MR. CLARKE:

There are a number of evidence items, aren't there?

157 DR. GERDES:

Yes.

158 MR. CLARKE:

And in fact there are remaining swatches from many of the very items that we've described that you have described during your testimony in this case?

159 DR. GERDES:

There are.

160 MR. CLARKE:

Whether it is the Bundy blood drops?

161 DR. GERDES:

Correct.

162 MR. CLARKE:

Whether it is DNA removed from the Bronco?

163 DR. GERDES:

Correct.

164 MR. CLARKE:

Whether it is DNA from the Defendant's home?

165 DR. GERDES:

Correct.

166 MR. CLARKE:

Whether it is DNA on the glove?

167 DR. GERDES:

Correct.

168 MR. CLARKE:

Whether it is DNA on the socks?

169 DR. GERDES:

Correct.

170 MR. CLARKE:

Have you tested any of that?

171 DR. GERDES:

We don't do this type of testing.

172 MR. CLARKE:

Well, as far as the difference between the testing, you do in your laboratory and forensic labs do, you have testified the only difference is the nature of the specimen, a bloodstain versus a blood vial, correct?

173 DR. GERDES:

No. I believe I testified that it is comparing apples and oranges, that it is a completely different set-up and statistics involved in paternity from forensics, they really are not the same other than the fact that the methodology itself as far as how you run the gels is the same.

174 MR. CLARKE:

Dr. Gerdes, if you exclude somebody statistics don't mean anything, do they?

175 DR. GERDES:

That is true.

176 MR. CLARKE:

In other words, if you test a sample and a genetic marker, someone is excluded as having left a sample at a crime scene, let's say, numbers don't mean a thing?

177 DR. GERDES:

That's right.

178 MR. CLARKE:

As far as in your laboratory, you have tested the DQ-Alpha marker before, correct?

179 DR. GERDES:

Not in a forensic sense.

180 MR. CLARKE:

Have you tested the DQ-Alpha marker before, doctor?

181 DR. GERDES:

Yes.

182 MR. CLARKE:

And in that testing did you feel competent to perform that testing of the DQ-Alpha marker?

183 DR. GERDES:

Yes.

184 MR. CLARKE:

As far as removing DNA from a bloodstain, do you feel that you could do that?

185 DR. GERDES:

Yes, I could do that, but the--the difficulty is, as we have discussed over and over, whether that sample--you need to have confidence. The difference in the way I do things and the way forensics does that is I have confidence that a specimen I'm working with came from a single individual, and the complications in terms of statistics, interpretation, potential error, that is introduced by the fact that these are mixtures or potentially mixtures. That is the issue.

186 MR. CLARKE:

Dr. Gerdes, if one of those samples from the Bundy blood trail, 47 through 52, if one of those was typed and it revealed a genetic marker, and I am referring to the remaining evidence, that excluded Mr. Simpson, wouldn't that be important?

KEY QUOTE
187 DR. GERDES:

Yes.

188 MR. CLARKE:

That would be extremely important, wouldn't it?

189 DR. GERDES:

Yes.

190 MR. CLARKE:

Have you suggested to the Defense in this case that retesting should be done?

191 MR. SCHECK:

Objection.

192 THE COURT:

Sustained.

193 MR. SCHECK:

Objection, move to strike and ask for an instruction--

194 THE COURT:

Overruled.

195 MR. SCHECK:

--on burdens of proof.

196 MR. CLARKE:

Wouldn't reanalysis of these samples support, if they produced exclusionary results, support your opinions in this case?

197 MR. SCHECK:

Objection.

198 THE COURT:

Overruled.

199 DR. GERDES:

Not at this point.

200 MR. CLARKE:

Is it your view then that if further testing in this case revealed Mr. Simpson was excluded from item 52, that wouldn't support any of the opinions you've offered in this case about forensic DNA typing?

201 DR. GERDES:

In my opinion, with the risk of contamination, there would be no possible PCR interpretation possible at this point, because the samples have been handled in the way they have been.

KEY QUOTE
202 MR. CLARKE:

Are you aware of other laboratories--

203 THE COURT:

Keep going.

204 MR. CLARKE:

Are you aware of other laboratories, doctor, that perform forensic retesting?

205 DR. GERDES:

Yes.

206 MR. CLARKE:

Does Dr. Blake--is he able to perform DQ-Alpha typing on forensic specimens?

207 DR. GERDES:

Yes.

208 MR. CLARKE:

Is Mr. Taylor able to perform retesting on forensic specimens?

209 DR. GERDES:

Yes.

210 MR. CLARKE:

Is Dr. Lee able to perform forensic testing on specimens using DNA typing?

211 DR. GERDES:

Yes.

212 (Discussion held off the record between the Deputy District Attorneys.)
213 MR. CLARKE:

Could I have just a moment, your Honor? I'm sorry.

214 (Discussion held off the record between the Deputy District Attorneys.)
215 MR. CLARKE:

Thank you. Nothing further, your Honor.

Temperature

tense

Key Quotes (4)

Dr. John Gerdes
I don't have a hundred percent assurance that this did happen. I have no scientific confidence that it couldn't have happened.
Gerdes's most candid articulation of his position — he is arguing possibility, not proof, which Clarke had been pushing him toward all session.
Dr. John Gerdes
It didn't.
Gerdes concedes the defendant's reference sample never came into potential contact with the Bronco evidence stains, directly undermining the contamination theory for that key location.
Dr. John Gerdes
In my opinion, with the risk of contamination, there would be no possible PCR interpretation possible at this point, because the samples have been handled in the way they have been.
Clarke exposes a logical trap: Gerdes claims contamination risk is so high that even exculpatory retesting results would be meaningless, making his theory unfalsifiable.
George Clarke
Dr. Gerdes, if one of those samples from the Bundy blood trail, 47 through 52, if one of those was typed and it revealed a genetic marker...that excluded Mr. Simpson, wouldn't that be important?
Clarke's most pointed rhetorical move — implying the defense deliberately avoided retesting that could have proven their contamination theory.

Evidence (5)

People's 572
Slide summarizing Yamauchi's PCR typing sessions on June 14-15, showing 42 total samples including 21 controls
introduced and discussed
Informal
Bundy blood drop samples items 47-52, remaining swatches available for retesting
discussed
Informal
Rockingham glove with RFLP matches to two victims
discussed — Gerdes conceded RFLP matches were correct
Informal
Socks found at Rockingham residence with DNA consistent with Simpson and Nicole Brown
discussed — Gerdes conceded consistency
Informal
Ford Bronco DNA samples consistent with mixture of Simpson, Goldman, and Brown
discussed

Notable Exchanges (3)

George ClarkeDr. John Gerdes
Clarke repeatedly pressed Gerdes on whether Simpson's reference sample contaminated Bronco evidence, extracting the admission that it 'didn't' come into potential contact — then immediately moved to show the contamination theory lacked direct evidence for multiple key items.
strategic
George ClarkeDr. John Gerdes
Clarke walked Gerdes through the retesting trap: acknowledged experts (Blake, Taylor, Lee) are capable of forensic retesting, remaining evidence exists for nearly every item Gerdes criticized, yet no retesting was requested. Gerdes ultimately claimed the contamination risk was now so severe that no PCR result could be trusted — even exculpatory ones.
devastating
George ClarkeDr. John Gerdes
Clarke established that 50% of Yamauchi's 42 samples were controls, and Gerdes conceded this was an adequate number — undermining his own prior criticism of the lab's methodology.
revealing

Credibility Attacks (3)

⚔ Dr. John Gerdes
logical trap / unfalsifiability
Clarke forced Gerdes to admit that even retesting producing exclusionary results would not, in Gerdes's view, support his contamination opinions — because the samples are too contaminated to trust. Clarke exposed this as making the contamination theory scientifically unfalsifiable.
⚔ Dr. John Gerdes
concession extraction
Clarke methodically obtained concessions that the DNA results from all three labs are consistent with Simpson's guilt across every major evidence location: crime scene, Bronco, Rockingham, glove, and socks — while Gerdes could only offer 'multiple explanations' as a hedge.
⚔ Dr. John Gerdes
scope limitation
Clarke established that Gerdes's knowledge of non-DNA evidence came only from TV, newspapers, and magazines — not from reviewing case documents — limiting his ability to speak to the overall evidentiary picture.

Witness Demeanor

(Witness steps down from stand to view exhibit on screen)
(Witness complies with request to approach exhibit)

Objections

12 objections (3 sustained, 7 overruled)
Proceeding 7210 • 215 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 AUG 7, 1995 📄 Cross-examination of Dr. John
AUG 7, 1995 KRT DvH TD